PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 93 filers reported holding PMV PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,915,554 | -1.9% | 1,614,911 | 0.0% | 48.05% | +16.5% |
| Q2 2023 | $10,109,343 | +31.2% | 1,614,911 | 0.0% | 41.23% | +11.4% |
| Q1 2023 | $7,703,125 | -45.2% | 1,614,911 | 0.0% | 37.02% | -45.2% |
| Q4 2022 | $14,049,726 | -26.9% | 1,614,911 | 0.0% | 67.54% | +14.0% |
| Q3 2022 | $19,217,000 | -16.5% | 1,614,911 | 0.0% | 59.24% | +38.5% |
| Q2 2022 | $23,012,000 | -65.8% | 1,614,911 | -50.1% | 42.78% | +66.3% |
| Q1 2022 | $67,351,000 | -9.9% | 3,234,911 | 0.0% | 25.73% | -41.8% |
| Q4 2021 | $74,726,000 | -35.2% | 3,234,911 | -16.4% | 44.17% | -7.5% |
| Q3 2021 | $115,323,000 | -32.1% | 3,869,911 | -22.1% | 47.76% | -10.8% |
| Q2 2021 | $169,772,000 | -5.6% | 4,969,911 | -9.1% | 53.57% | +13.2% |
| Q1 2021 | $179,905,000 | -54.8% | 5,469,911 | -15.5% | 47.32% | -4.8% |
| Q4 2020 | $397,964,000 | +73.3% | 6,469,911 | 0.0% | 49.71% | -25.0% |
| Q3 2020 | $229,682,000 | – | 6,469,911 | – | 66.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,614,911 | $9,915,554 | 48.05% |
| OUP Management Co., LLC | 989,232 | $6,073,884 | 13.66% |
| Euclidean Capital LLC | 5,255,286 | $32,267,456 | 3.52% |
| Tri Locum Partners LP | 821,384 | $5,043,298 | 1.61% |
| Ghost Tree Capital, LLC | 705,881 | $4,334,109 | 1.42% |
| Boxer Capital, LLC | 3,163,795 | $19,425,701 | 1.03% |
| Mesirow Financial Investment Management, Inc. | 34,748 | $213,353 | 0.93% |
| Orbimed Advisors | 6,563,077 | $40,297,293 | 0.86% |
| Octagon Capital Advisors LP | 904,000 | $5,550,560 | 0.85% |
| Nextech Invest Ltd. | 421,284 | $2,586,684 | 0.78% |